Champions Oncology, Inc. (CSBR)

NASDAQ

$4.91

$-0.24

(-4.66%)

Regular Market

Champions Oncology, Inc. (CSBR) Live Price Chart

Last updated: ⁦2026-10-21 19:32:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Champions Oncology, Inc. (CSBR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $4.91, with a market capitalization of $65.28M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.59 to $8.31. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$65.28M
Open	$5.15
Day's High	$17.90
Day's Low	$1.11
Previous Close	$4.81
Volume	2.29K
Average Volume	11.16K
P/E Ratio	--
52-Week High	$8.31
52-Week Low	$4.59
Dividend Yield	--
Earnings Date	--

Champions Oncology, Inc. (CSBR) Stock Price Today

Champions Oncology, Inc. (CSBR) is currently trading at $4.91 as of 2026-10-21 19:28:00, up 2.08% ($0.10) from the previous close of $4.81

During today's regular trading session, CSBR has traded between $1.11 and $17.90, with a trading volume of 2.29K shares. The current price is near the lower end of today's range.

Champions Oncology, Inc. (CSBR) 7-Day Stock Price Change

Over the past seven days, Champions Oncology, Inc. (CSBR) moved from $4.95 to $4.91, representing a decline of 0.87% ($0.04).

The stock traded between $4.63 and $5.15 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 6.55 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

CSBR 52-Week Price Position

Position in Range: 8.6%

52W Low$4.59

52W High$8.31

CSBR is currently trading at $4.91, placing it 8.6% of the way from its 52-week low of $4.59 to its 52-week high of $8.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Champions Oncology, Inc. (CSBR)?

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

Champions Oncology, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	214
Exchange	NASDAQ
Company Website	https://www.championsoncology.com

How to Buy Champions Oncology, Inc. (CSBR) Stock on MEXC

Eligible investors can buy real shares of Champions Oncology, Inc. (CSBR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CSBR and Place Your Order

Open the RealStocks trading page and search for CSBR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Champions Oncology, Inc. (CSBR) stock price today?

Champions Oncology, Inc. (CSBR) is currently trading at $ 4.91, up 2.08% ($0.10) from the previous close of $ 4.81. Intraday prices update in real time during regular trading hours.

2.Is CSBR stock going up or down today?

As of 2026-10-21 19:28:00, CSBR is trading at $ 4.91, up 2.08% ($0.10) from its previous close of $ 4.81. The stock has traded between $ 1.11 and $ 17.90 during today’s regular session. Past price movements do not guarantee future results.

3.What is CSBR pre-market price?

As of 2026-10-21 19:28:00, CSBR is trading at $ 4.79 in pre-market trading, down 0.33% ($0.02) from the previous close of $ 4.81. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CSBR after-hours price?

As of 2026-10-21 19:28:00, CSBR is trading at $ 4.78 in after-hours trading, down 0.71% ($0.03) from the regular-session close of $ 4.81. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CSBR stock trading now?

CSBR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CSBR sit relative to its 52-week high and low?

Over the past 52 weeks, CSBR has traded between a low of $ 4.59 and a high of $ 8.31. At $ 4.91, the stock is positioned 8.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Champions Oncology, Inc. in?

Champions Oncology, Inc. (CSBR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Champions Oncology, Inc.'s market capitalization and where is it listed?

Champions Oncology, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 65.28M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CSBR valued in terms of P/E ratio and EPS?

CSBR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.08. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Champions Oncology, Inc. pay a dividend?

Champions Oncology, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.